FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal Cancer
Condition: Colorectal Cancer Metastatic Intervention: Drug: Oxaliplatin Sponsors: Criterium, Inc.; Amgen Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials